A Novel Marker for Predicting Fulminant Myocarditis: Systemic Immune–Inflammation Index
Authors:
- Raziye Merve YaradilmişRYRaziye Merve Yaradilmiş
- Muhammed Mustafa GüneylioğluMGMuhammed Mustafa Güneylioğlu
- Betül ÖztürkBÖBetül Öztürk
- Aytaç GöktuğAGAytaç Göktuğ
- Orkun AydınOAOrkun Aydın
- Ali GüngörAGAli Güngör
- İlKnur BodurIBİlKnur Bodur
- Özkan KayaÖKÖzkan Kaya
- Utku Arman ÖrünUÖUtku Arman Örün
- Can Demir KaracanCKCan Demir Karacan
- Nilden TuygunNTNilden Tuygun
- 19 August 2022
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 44 (3) , 647-655
Abstract
In myocarditis, the search for effective and appropriate prognostic biomarkers can help clinicians identify high-risk patients in a timely manner and make better medical decisions in clinical practice. The prognostic value of systemic immune–inflammatory index (SII), an innovate biomarker of inflammation, in fulminant myocarditis in children has not been assessed. This study aims to (1) determine the effect of SII and other inflammatory markers on the prognosis of patients with myocarditis, and (2) characterize other factors affecting adverse outcomes in myocarditis. All patients aged between 1 months and 18 years who admitted to Pediatric Emergency Department between January 1, 2015 and October 1, 2021 and were diagnosed with myocarditis were retrospectively analyzed. 106 Eligible subjects were enrolled (67% male, 12.5 years (IQR 6–16). Fulminant myocarditis developed in 16 (15%) of the patients. The median SII was 1927 (1147.75–3610.25) in the fulminant myocarditis group and 351 (251.75–531.25) in the non-fulminant group (p < 0.001). In estimation of fulminant myocarditis, AUC was 0.87 for WBC [95% confidence interval (CI) 0.72–1.00, p = 0.002], 0.94 for ANC (95% CI 0.85–1.00), p = 0.000), 0.92 for SII (95% CI 0.82–1.00, p = 0.000). Spearman’s correlation analysis showed a significant negative correlation between SII and LVEF (r = 0.576, p < 0.001). The highest AUC values were associated with ANC, SII, and WBC levels to predict fulminant myocarditis. SII, a readily available biomarker from routine blood parameters, allows early recognition of negative outcomes and can independently predict the prognosis of myocarditis in children.Keywords
This publication has 20 references indexed in Scilit:
- Systemic immune‐inflammation index, neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio can predict clinical outcomes in patients with metastatic non‐small‐cell lung cancer treated with nivolumabJournal of Clinical Laboratory Analysis, 2019
- Immature granulocytes index as early marker of sepsisInternational Journal of Laboratory Hematology, 2019
- Diagnostic performance of serum CK-MB, TNF-α and hs-CRP in children with viral myocarditisOpen Life Sciences, 2019
- Elevated Troponin in the First 72 h of Hospitalization for Pediatric Viral Myocarditis is Associated with ECMO: An Analysis of the PHIS+ DatabasePediatric Cardiology, 2018
- Occurrence and Features of Childhood Myocarditis: A Nationwide Study in FinlandJournal of the American Heart Association, 2017
- Analysis of Clinical Parameters and Cardiac Magnetic Resonance Imaging as Predictors of Outcome in Pediatric MyocarditisThe American Journal of Cardiology, 2015
- Diagnosis and Treatment of Myocarditis in Children in the Current EraCirculation, 2014
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesEuropean Heart Journal, 2013
- Management of acute myocarditis in children.2013
- The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurementsEuropean Heart Journal, 2005